Abstract
Human adipose tissue derived mesenchymal stromal cells (AdMSC) have great potential as therapies for a variety of diseases. To ensure accurate dosing, we need a fast and reproducible solution for assessment of AdMSCs prior to release as clinical therapy products. The traditional method of manual counting (hemocytometer and trypan blue) can be time consuming and has potentially high user variability. A number of automated counting systems provide the potential for decreased turnaround time and improved accuracy and consistency.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
